A controversial aspect of the operation of pharmaceutical manufacturing firms that continues to be an issue is the use of “pay-for-delay” contracts.
Caroline H. Cecka, PharmD/MBA Candidate
Advertisement
Articles by Caroline H. Cecka, PharmD/MBA Candidate
Advertisement
Latest Updated Articles
Will US Senate Address Pay-for-Delay Agreements?Published: February 21st 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health
2
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
3
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
4
Menopause Care Varies by Provider, Highlighting Need for Standardized Education
5
